Sanger science

The Wellcome Sanger Institute tackles some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.

EMBL's European Bioinformatics Institute science

EMBL-EBI is international, innovative and interdisciplinary, and a champion of open data in the life sciences. It is part of the European Molecular Biology Laboratory (EMBL), an intergovernmental research organisation funded by over 20 member states, prospect and associate member states.

Connecting with industry

We’re moving towards a stage at which genomics will be integrated into every part of our lives.

Convergence and coordination across technology fields and the public, the private and the charitable sectors will be key to driving the next wave of genomic innovation. Watch this video to hear from some of our collaborators and how science at scale is helping us transform the way we innovate.

 

I find it exciting and inspiring to be part of the Wellcome Genome Campus where innovative science with impact is taking place: from discovering how cancer forms to tracking the spread of superbugs in real-time. There is a real buzz to the Campus; we know that the next breakthrough is just around the corner.

Gene Koh, PhD Student, Wellcome Sanger Institute

92

faculty staff across EMBL-EBI and Wellcome Sanger Institute

4,500

papers published in the last five years (combined total output from Sanger Institute and EMBL-EBI)

245

individuals working across 10 companies based in the BioData Innovation Centre

>350

scientific seminars, lectures and talks open to all Campus staff